Raj, R., A. Kumar, Prachi Sood, R. Kumar, and V. Rana. “Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer”. Journal for Research in Applied Sciences and Biotechnology, vol. 2, no. 3, June 2023, pp. 55-63, doi:10.55544/jrasb.2.3.8.